Australia, Oct. 16 -- TREELINE BIOSCIENCES Inc., owns the trademark (2528533) for 'TREELINE' till March 7, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical products; biological preparations; pharmaceutical preparations for the prevention and treatment of cancer, autoimmune immunologic-based diseases and other human diseases; biological preparations for the prevention and treatment of cancer, autoimmune diseases immunologic-based diseases and other human diseases; pharmaceutical, biological, and medicinal preparations for use in combination with other therapies for the treatment and prevention of cancer, autoimmune diseases, immunologic-based diseases and other human diseases; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes] and 42 [Pharmaceutical research and development; medical, pharmaceutical, and scientific research in the field of cancer, autoimmune diseases, immunologic-based diseases and other human diseases; medical, pharmaceutical, and scientific research in the field of biomarkers; clinical research and testing services; conducting clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials]
Type of Mark: Word
Date of Acceptance: May 7
Registration Advertised: Oct. 15
For further details contact AJ Park.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2528533.
Disclaimer: Curated by HT Syndication.
